LINC02152

Across TCGA pan-cancer cohorts, LINC02152 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated LINC02152 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher LINC02152 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02152 expression acts as an unfavorable survival marker, although some lineages such as LUSC and ESCA show a favorable association.

KIRC, BRCA, and COAD are the cancer types where LINC02152 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	II,III,IV	0.367	0.584	<.001	114	view →
BRCA	DFS	Quartile	III,IV	0.310	0.504	.003	78	view →
COAD	OS	Tertile	All	0.770	0.880	.004	60	view →
LUAD	DFS	Tertile	IV	0.316	0.791	<.001	54	view →
KIRP	DFS	Tertile	III,IV	0.168	0.724	.005	45	view →
LIHC	OS	Median	All	0.612	0.780	.002	30	view →
LUSC	OS	Tertile	All	0.839	0.741	.005	24	view →
ESCA	DFS	Median	III,IV	0.464	0.247	.016	20	view →
READ	OS	Tertile	III,IV	0.284	0.802	.001	18	view →
ACC	DFS	Tertile	IV	0.012	0.310	.002	18	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	15	view →
STAD	DFS	Median	IV	0.130	0.503	.001	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

LINC02152–KIRC (DFS)

Open the KIRC breakdown →